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This study determined noncompliance to antihypertensive therapy (AHT) and its associated factors in a Ghanaian population
by using the health belief model (HBM). This descriptive cross-sectional study conducted at Kintampo Municipality in Ghana
recruited a total of 678 hypertensive patients. The questionnaire constituted information regarding sociodemographics, a five-
Likert type HBM questionnaire, and lifestyle-related factors. The rate of noncompliance to AHT in this study was 58.6%. The
mean age (SD) of the participants was 43.5 (±5.2) years and median duration of hypertension was 2 years. Overall, the five HBM
constructs explained 31.7% of the variance in noncompliance to AHT with a prediction accuracy of 77.5%, after adjusting for age,
gender, and duration of condition. Higher levels of perceived benefits of usingmedicine [aOR=0.55(0.36-0.82),p=0.0001] and cue to
actions [aOR=0.59(0.38-0.90),p=0.0008] were significantly associated with reduced noncompliance while perceived susceptibility
[aOR=3.05(2.20-6.25), p<0.0001], perceived barrier [aOR=2.14(1.56-2.92), p<0.0001], and perceived severity [aOR=4.20(2.93-
6.00),p<0.0001] were significantly associated with increased noncompliance to AHT. Participant who had completed tertiary
education [aOR=0.27(0.17-0.43), p<0.0001] and had regular source of income [aOR=0.52(0.38-0.71), p<0.0001] were less likely to
be noncompliant. However, being a government employee [aOR=4.16(1.93-8.96), p=0.0002)] was significantly associated increased
noncompliance to AHT. Noncompliance to AHT was considerably high and HBM is generally reliable in assessing treatment
noncompliance in the Ghanaian hypertensive patients. The significant predictors of noncompliance to AHT were higher level of
perceived barriers, susceptibility, and severity. Intervention programmes could be guided by the association of risk factors, HBM
constructs with noncompliance to AHT in clinical practice.
1. Background
Hypertension (HTN) is a major risk factor for cardiovascular
diseases such as heart failure, myocardial infarction, and
stroke [1–4]. Cardiovascular diseases are the major cause
of mortality among adults globally [1] of which about 50%
can be ascribed to complications of HTN [5]. Developing
countries account for almost 80% of these deaths [5]. Among
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the list of noncommunicable diseases plaguing the general
Ghanaian population, HTN is said to be the most prevalent
[6, 7]. Efforts geared towards improving lifestyles, controlling
lifestyle-related major cardiovascular risk factors, absolutely
will contribute to the prevention of cardiovascular diseases
[1, 5]. The Ghana Health Service (GHS) also estimated that
the prevalence rate ofHTN inGhana among adults of 18 years
and above was 29.9 per cent for males and 27.6 per cent for
females (GHS, 2014). It has been reported that blood pressure
(BP) control among hypertensives in Ghana is largely poor
due to noncompliance to therapy [8]. Noncompliance to
antihypertensive therapy (AHT) involves the interplay of the
healthcare-provider/health system, therapy, condition, client,
and socioeconomic factors [3, 8, 9].
The annual health report of the Kintampo Municipality
continues to show HTN ranking among the top 10 diseases
over the past 5 years (Municipal Health Year Report, 2015).
Moreover, it was the fourth leading cause of death in the
municipality. Failure to maintain a well-controlled blood
pressure (BP) has been mainly attributed to noncompliance
to AHT [2, 3]. To the best of our knowledge, no published
study has been conducted to determine noncompliance
among hypertensives in the municipality. The health belief
model (HBM) is one of the most classical theories devised
by social psychologists to describe social behaviour as well as
public participation inmedical programs [10].Themodel was
further extended to the study of range of health behaviours
which included dietary behaviour, smoking, contraceptives,
physical activities alcohol use and drinking, and obstetrics
outcome [11–13]. The model contains several cognitive con-
structs that predict why people take actions to control their
illness including perceived susceptibility, perceived severity,
perceived benefits, perceived barriers, and cues to actions.
HBM has strength to allow patient diagnosed with HTN
to consider the benefits to be gained from compliance
(behaviour), is worth the cost, and also assess his or her
severity and vulnerability to HTN complications before
making the decision [14]. There is limited research evidence
on the implications of health behaviour from low income
countries such as Ghana, although the applications of this
model have been widely used in developed countries. Several
studies have investigated the prevalence of antihypertensive
compliance and its determinants in Ghana [15–18]; no study
has focused on the applicability of HBM. It was against this
background that the study sought to evaluate noncompliance
to AHT among Ghanaian hypertensive patients using HBM.
2. Material and Methods
2.1. StudyDesign and Setting. This studywas a cross-sectional
descriptive study among hypertensives attending the Hyper-
tension Clinic at the Kintampo Municipal Hospital. The
Kintampo Municipal Hospital is the major source of health
care for the inhabitants of the Kintampo Municipality. The
Hypertension Clinic was established in April 2015 under the
auspices of the Kintampo Municipal Health Directorate and
operates only on Wednesdays. The clinic is being run by
a medical doctor, a physician assistant, a general nurse, an
enrolled nurse, and two health extension workers.
2.2. Study Population and Subject Selection. The targeted
population was hypertensive patients who were on antihy-
pertensive therapy and attending the Hypertension Clinic.
Simple random sampling technique was used to recruit six
hundred and seventy-eight (678) hypertensive patients who
consented for the study at the Hypertension Clinic at the
KintampoMunicipal Hospital. Each hypertensive patient was
given a number and then a table of randomnumbers to decide
which patient to include. Depending on the total number of
patients per each clinic, a range of 20 to 24 patients were
randomly sampled weekly until sample size was achieved.
Hypertensive patients who had been diagnosed or were on
medication for hypertension for one year or more were
included in the study as well as hypertensive patients aged
30 years and above. Moreover, hypertensives with or without
other existing comorbidities such as diabetes, cardiovascular
diseases, and renal diseases were also included in the study.
Hypertensive patientswhodid not consent andwere seriously
ill (too sick to be interviewed) were excluded from the study
2.3. Data Collection Tool. For validity and reliability of the
study, a pilot study was conducted using the research instru-
ment. This was aimed at testing the strength of the research
instrument to elicit the needed responses for the study. The
pilot study was carefully evaluated by the researchers and an
expert in the field of research. Necessary amendments were
made and the resulting questionnaire was used for the main
data collection process. Reliability coefficients ranging from
0.00 to 1.00, with higher coefficients indicating higher levels
of reliability, were used to determine the validity and the
reliability of the questionnaire. The reliability coefficients for
all the questions were 0.903.
The questionnaire developed for this study was adopted
from studies conducted by Joho [19]. It was made up of three
sections. Section A collects the sociodemographic character-
istics data of the participants. Section B was designed to col-
lect information on treatment compliance, which comprised
both medication regimen compliance and lifestyle modifi-
cation. Medication regimen compliance was composed of 8
items, asking how often they forgot to take their medicine,
did they stop taking their medicine because they felt better,
because they felt worse, because they believed that medicine
was ineffective, because they feared side effects, because
they tried to avoid addiction, because of religious beliefs
or they were using traditional medicine, and because of
cost of medication. The responses were measured on a 4-
point Likert scale (every day, frequently, rarely, or never).
Lifestyle compliance composed of 5 items which included
how often they did smoke, consumed alcohol, engaged in
physical exercise, ate table salt, and ate meat with high animal
fats. Participants were asked to respond to the single question
based on a 4-point Likert scale: how often do desirable or
undesirable behaviours related to control of hypertension.
The responses were every day, frequently, rarely, or never.The
responses were (1) every day, (2) frequently, (3) rarely, or (4)
never. Some questions were set such that the highest score did
not reflect the worst scenario of noncompliance. To resolve
this, scores were reversed. For instance, how often do you
engage in physical exercise: (4) every day, (3) frequently, (2)
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rarely, or (1) never. Section C constituted the HBM variables
which include perceived severity of hypertension measured
by six items which included whether BP was a serious
problem, worried about their HTN condition, getting HTN
was serious, getting HTN complications was very dangerous,
and dying due HTN complication was dangerous; perceived
susceptibility of being at risk of hypertension complications
measured by six items, thus having stroke, developing visual
impairment, heart problems, kidney problems, becoming
burden for family, and career being negatively affected;
perceived benefit treatments were eachmeasured by six items
which were keeping their BP under control, increasing their
quality of life, increasing their sense of well-being, protecting
them from complications, avoiding added financial burden
to treat complications, and decreasing my chance of dying;
and cues to actionweremeasured by seven items. Participants
were then asked to respond strongly agree (4), agree (3),
disagree, (2) or strongly disagree (1). The remainder which is
perception of barriers was also measured by five items, inef-
fective of themedicine to stabilize their BP, lack ofmotivation
because they cannot be cured, not having enough time to
exercise, lack of discipline to comply with dietary restriction,
and lack of motivation to stop smoking. The responses were
‘not at all’ (1), ‘to some extent’ (2), ‘to a larger extent’ (3),
or ‘very much extent’ (4). The 13 items measuring treatment
compliance and life style compliance were added up to get
sum index with a distribution ranging from 23 to 52 with
mean 44.30 (SD =5.55), and the median split was used (46.0),
which was dichotomized into two groups, i.e., 1 = those who
are nontreatment compliant and 0 = treatment compliant
which was 23-45 and 46-52. The variables comprising the
number of items measuring compliance in the HBM were
added up to get sum index with a distribution range, and
the median split was used as a cut point. Dichotomization
was done into two frequency groups, those who had low
perceived severity, susceptibility, benefits, and vice versa.
The entire questionnaire was available in English version
but interviewed carefully with the proper translation of the
official local language of the study population. The responses
of the participants were translated back to English in the
correct meaning as was interpreted.
2.4. Ethical Consideration. Approval for this study
was obtained from Human Research, Publication and
Ethics of the School of Medical Sciences (SMS), Kwame
Nkrumah University of Science and Technology (KNUST)
(CHRPE/AP/213/16). Participation was voluntary and
written informed consent was obtained from each
participant. Hypertensive clients were also given a short
exposition on the essence of the study and their role to play to
make it a success. The clients who were prospective subjects
for the study were made to understand that the research
was solely for academic purposes, and that no information
would be handled with anything short of full privacy and
confidentiality.
2.5. Statistical Analysis. Data was entered into excel work-
sheet and analysed using the statistical package for social
sciences version (SPSS) 23.0. Continuous variables were
Figure 1: Frequency distribution of noncompliance and compliance
among participants.
expressed as mean ± SD for normal distributed data and
median (interquartile range) for not normally distributed
data, respectively. Frequency distributions were done as
sociodemographic data and then bivariate analysis using chi-
squire for association of sociodemographic characteristics
andHBMwith treatment noncompliance; and Pearson corre-
lation between HBM variables was done. Logistic regressions
were done with treatment noncompliance as the outcome
variable and the rest of HBM variables as predictors. Statis-
tical significance was assumed at p<0.05.
3. Results
The mean age (SD) of the participants was 43.5(±5.2) years
and median duration of the disease was 2 years. Majority
of them were males (50.7%). Considerable proportions of
the participants had no education (34.2%), were married
(66.7%), and were private employees (50.8%). Most of the
participants have had the condition for less than 5 years
(72.0%).Moreover,more than half of the participants (60.8%)
did not have regular income [Table 1].
Three hundred and ninety-seven (58.6%) participants
were not compliant to AHT, while 41.4% complied [Figure 1].
Participants with high cues to actions and perceived ben-
efits had reduced odds for noncompliance [aOR=0.59(0.38-
0.90), p=0.0008);OR=0.55(0.36-0.82), p=0.0001)].Moreover,
participants with high perceptions of severity had signifi-
cantly increased odds for noncompliance [aOR=4.20(2.93-
6.00), p<0.0001)]. Participant with high perception of sus-
ceptibility [aOR=3.05, (2.20-4.25), p<0.0001)] and high per-
ceived barriers [aOR=2.14(1.56-2.92), p<0.0001)] were more
likely to be noncompliant to AHT [Table 2].
As shown in Table 3, treatment noncompliance showed
significant and positive association with perceived severity
(r=0.19, p<0.0001) and susceptibility (r=0.33, p<0.001). Fur-
thermore, treatment noncompliance was significantly nega-
tively associated benefits (r= -0.449, p<0.0001).
Participant who had completed tertiary education
had significantly reduced odds for noncompliance to
AHT [aOR=0.27(0.17-0.43), p<0.0001)]. However, being a
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Table 1: Sociodemographic characteristics of study participants.
Variables Frequency (n=678) Percentages (%)
Age (years) (Mean ± SD) 43.5±6.2
Age Groups
31-40 301 44.4%
41-50 264 38.9%
51-60 113 16.7%
Gender
Male 344 50.7%
Female 334 49.3%
Marital Status
Single 90 13.3%
Married 452 66.7%
Divorced 51 7.5%
Separate 38 5.6%
Widowed 30 4.4%
Cohabiting 17 2.5%
Education Level
Uneducated 232 34.2%
Basic 203 30.0%
SHS 115 16.9%
Tertiary 128 18.9%
Occupational Status
Government employee 230 33.9%
Private employee 344 50.7%
Self-employed 65 9.6%
Student 5 0.7%
Unemployed 34 5.0%
Duration of Condition(years)
<5 488 72.0%
5-10 179 26.4%
>10 12 1.6%
Regular Source Income
No 412 60.8%
Yes 266 39.2%
Duration of Condition (years) (Median, IQR) 2.0(1.0-5.0)
Duration of Treatment (years) (Median, IQR) 2.0(1.0-5.0)
SD: standard deviation, IQR: interquartile range, JHS: junior high school, and SHS: senior high school.
government employee [aOR=4.16(1.93-8.96), p=0.0002)]
was significantly associated with increased likelihood of
being noncompliant to AHT. Participants who had regular
source of income had lower odds for noncompliance to
AHT [aOR=0.52(0.38-0.71), p<0.0001)]. Being male [aOR=
1.33(0.98-1.81), p=0.074)], being divorced [aOR=2.00(0.98-
4.09, p=0.077)], and duration of HTN 5-10 years
[OR=1.37(0.96-1.95), p=0.092) had significant association
with noncompliance to AHT [Table 4].
Lifestyle-related factors such as number of medicine
taken (p=0.002), history of smoking (p<0.0001), and history
of alcohol consumption (p<0.0001) had statistically signif-
icant association with noncompliance to AHT. Moreover,
considerable proportions of the participants who had health
compliant other than HTN (73.0%) and those on two differ-
ent drugs (56.9%) were noncompliant to AHT [Table 5].
Multiple logistic regression analysis showed significant
model fit for the data (F=24.7, p< 0.0001). The amount of
variance in noncompliance to AHT which is explained by
the predictors is 31.7 % (R2=0.317) with perceived barrier
being the strongest predictor of noncompliance to AHT (𝛽 =
0.780, p< 0.0001). Positive beta coefficient indicates a positive
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Table 2: Association of constructs of HBM with participant’s treatment compliance.
Variables Non-compliance Compliance p-value aOR (95%CI)
Cues to Action 0.0008
Low 226(56.9%) 123(43.8%) 1
High 171(43.1%) 158(56.2%) 0.59(0.38-0.90)
Perception of benefits 0.0001
Low 233(58.7%) 123(43.8%) 1
High 164(41.3%) 158(56.2%) 0.55(0.36-0.82)
Perception of severity <0.0001
Low 201(50.6%) 228(81.1%) 1
High 196(49.4%) 53(18.9%) 4.20(2.93-6.00)
Perception of susceptibility <0.0001
Low 188(47.4%) 206(73.3%) 1
High 209(52.6%) 75(26.7%) 3.05(2.20-4.25)
Perception to barriers <0.0001
Low 179(45.1 %) 179(63.7%) 1
High 218(54.9%) 102(36.3%) 2.14(1.56-2.92)
aOR: adjusted odds ratio; CI: confidence interval; p<0.05 is statistically significant; and 1∗ reference category.
Table 3: Partial correlation between HBM constructs controlling for age, gender, and duration of disease.
Variables 1 2 3 4 5 6
1.Treatmen non-compliance r - 0.19 0.33 -0.21 -0.449 -0.012
p-value <0.0001 <0.0001 <0.0001 <0.0001 0.820
2.Perceived Severity r - 0.539 -0.013 -0.294 0.087
p-value <0.0001 0.808 <0.0001 0.099
3.Perceived Susceptibility r - 0.067 -0.538 0.339
p-value 0.206 <0.0001 <0.0001
4.Perceived Benefits r - 0.018 0.464
p-value 0.735 <0.0001
5.Perceived Barriers r - 0.111
p-value 0.036
6.Cues to Action r -
p-value
r: correlation coefficient; p<0.05 is statistically significant.
association between perceived barriers and noncompliance
to AHT [Table 6].
4. Discussion
This study determined noncompliance to AHT and its asso-
ciated factors among hypertensive patients in the Kintampo
Municipality using HBM questionnaire.The rate of noncom-
pliance to AHT was 58.6% which indicates that more than
half of the participants were not complaint to their medi-
cation. This observed prevalence rate is lower compared to
other cross-sectional studies done in the Ghanaian setting by
Kretchy et al. [15] andBuabeng et al. [16] but higher compared
to a study by Jambedu amongGhanaian hypertensive patients
[17].Thepossible explanations for these disparities in findings
could be due to the differences in sample size and the type
of questionnaire used, as previous studies did not employ
the HBM. Conversely, the observed noncompliance rate in
this current study is comparable to range of reports from
previous cross-sectional studies done elsewhere in Africa [8,
20–22]. These results highlight the fact that noncompliance
to AHT is very common in the Ghanaian setting. The high
noncompliance rate reported in this study is also consistent
with some cross-sectional studies in Pakistan [23, 24], China
[25, 26], and Iran [27].
Several retrospective and prospective studies have pro-
vided extensive support for the HBM in evaluating a range
of health-related behaviours, although some other studies do
not fully support this theory [11, 28, 29].TheHBMperformed
fairly well in predicting noncompliance to AHT among
Ghanaian hypertensive patients in this study. The amount
of variance in treatment noncompliance which is explained
by the five constructs was 31.7 % with an overall prediction
accuracy of 77.5% after adjusting age, gender, and duration
of condition. This indicates that HBM is generally reliable in
predicting noncompliance to AHT and framing intervention
6 International Journal of Hypertension
Table 4: Sociodemographics of study participants and relation to compliance.
Variables Non-compliance Compliance X2, df P-value aOR (95% CI) p-value
Age Groups (years) 1.3,2 0.519
31-40 167(42.1%) 134(47.7%) 1
41-50 164(41.3%) 100(35.6%) 1.32(0.94-1.84) 0.124
51-60 66(16.6%) 47(16.7%) 1.13(0.73-1.75) 0.657
Gender
Male 214(53.9%) 130(46.2%) 1.33(0.98-1.81) 0.074
Female 187(46.1%) 151(53.8%) 1
Marital Status 3.6, 6 0.724
Single 45(11.3%) 45(16.0%) 1
Married 264(66.5%) 189(67.3%) 1.40(0.88-2.20) 0.163
Divorced 34(8.6%) 17(6.0%) 2.00(0.98-4.09) 0.077
Separate 23(5.8%) 15(5.4%) 1.53(0.71-3.31) 0.334
Widowed 20(5.0%) 9(3.2%) 2.22(0.91-5.41) 0.089
Cohabiting 11(2.8%) 6(2.1%) 1.83(0.62-5.39) 0.301
Educational Level 20.8, 4 <0.0001
Unschooled 154(38.9%) 77(27.4%) 1
Basic 132(33.2%) 72(25.6%) 0.92(0.61-1.36) 0.686
SHS 66(16.6%) 49(17.4%) 0.67(0.42-1.07) 0.098
Tertiary 45(11.3%) 83(29.6%) 0.27(0.17-0.43) <0.0001
Occupational Status 13.1, 4 0.011
Government employee 153(38.5%) 77(27.4%) 4.16(1.93-8.96) 0.0002
Private employee 201(50.6%) 143(50.9%) 2.94(1.39-6.22) 0.006
Self-employed 32(8.1%) 32(11.4%) 2.09(0.88-4.99) 0.134
Student 0(0.0%) 6(2.0%) - -
Unemployed 11(2.8%) 23(8.2%) 1
Duration of Condition(years) 1.8,2 0.411
<5 277(69.8%) 211(75.1%) 1
5 -10 115(29.0%) 64(22.8%) 1.37(0.96-1.95) 0.092
>10 5(1.2%) 6(2.1%) 0.63(0.19-2.11) 0.544
Regular Source Income 10.0,1 0.007
No 267(67.2%) 145(51.6%) 1
Yes 130(32.8%) 136(48.4%) 0.52(0.38-0.71) <0.0001
X2: Chi-square, df: degree of freedom, aOR: adjusted odds ratio, CI: confidence interval, JHS: junior high school, and SHS: senior high school; p<0.05 is
statistically significant;∗1 reference category.
measures to reduce noncompliance to AHT amongGhanaian
hypertensive patients.
Perceived barrier was observed to be the strongest pre-
dictor of treatment noncompliance which is consistent with
finding observed by Day et al. [30]. It was also observed
that higher levels of perceived barriers were associated with
increased odds of noncompliance to AHT. This result corre-
sponds closely to finding from previous study conducted by
Haynes et al., who reported that perceived barrier was the
strongest predictor of noncompliance to AHT [31]. Higher
perceived benefit of using medicine and cue to actions
significantly correlated with reduced odds of noncompliance
to AHT. These findings concur with current literature on
hypertensive medication adherence among Chinese [25, 32].
Thus, intervention measures suitable for Ghanaian hyper-
tensive patients should mainly focus on reducing perceived
susceptibility, perceived severity, and perceived barriers but
increase cues to action and perceived benefits.
In this study, the average age of all included hyperten-
sive patients was 43.5 years indicating high prevalence of
hypertension in younger adults compared to the elderly.
This is inconsistent with studies by Almas et al. [33] and
Okwuonu et al. [20], where mean age within the fifties were
reported, depicting higher prevalence of hypertension among
the elderly. However, current literature indicates that the
prevalence rate of hypertension in the Ghanaians population
is higher in the 40-55 years age groups [16, 34, 35]. Our
current study confirms this change of trend, where now the
prevalence is higher in those in their forties and fifties. The
high prevalence in the young adults in our population could
be due to change in lifestyle and adaptation of Westernized
diets, full of salts and fats that could predispose them
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Table 5: Association of lifestyle-related factors with treatment noncompliance.
Variables Non-compliance Compliance P-value
Health complaint other than HTN 0.069
Yes 290(73.0%) 223(79.3%)
No 107(27.0%) 58(20.7%)
Number of Medicine taken 0.002
1 38(9.6%) 8(2.9%)
2 226(56.9%) 177(63.0%)
3 115(29.0%) 90(32.0%)
≥4 18(4.5%) 6(2.1%)
History of smoking <0.0001
No 344(86.6%) 279(99.3%)
Yes 53(13.4%) 2(0.7%)
History of alcohol consumption <0.0001
No 269(67.8%) 257(91.4%)
Yes 128(32.2%) 24(8.6%)
P<0.05 is statistically significant.
Table 6: Cross-sectional association and predictability of HBM variables for noncompliance.
Health belief model variables Beta SE aOR (95%) P-value
Perceived Severity -0.007 0.078 0.99(0.25-1.78) 0.933
Perceived susceptibility 0.142 0.067 1.15(0.75-2.72 0.034
Perceived benefits -0.414 0.099 0.66(0.09-1.62) <0.0001
Perceived barriers 0.780 0.115 2.18(1.09-4.12) <0.0001
Cues to actions -0.006 0.062 0.98(0.22-1.64) 0.925
R2=0.317, F=24.7(p<0.0001), SE: standard error, p<0.05 is statistically significant, and aOR: adjusted odd ratio.
to hypertension. Moreover, logistic regression models in
this study showed that participants within 41-50 years had
increased odds for noncompliance to AHT. The majority
of the previous studies had shown that age is related to
compliance, although a few researchers found age not to be
a factor causing noncompliance [36–38]. Patients in this age
ranges (middle-aged patients) always have other priorities in
their daily life; due to their work and other commitments,
they may not be able to attend for treatment or spend a long
time waiting for clinic appointments
Participants who have had tertiary education had signif-
icant reduced odds for noncompliance to AHT in this study.
This is consistent with studies by Okuno et al. [39], Ghods
andNasrollahzadeh [40], and Yaruz et al. [41] who found that
patientswith higher educational level have higher compliance
to their medication. Intuitively, it may be expected that
patients with higher educational level should have better
knowledge about the disease and therapy and therefore be
more compliant. Sufficient knowledge about hypertension
in patients has been associated with greater medication
adherence and better BP control in previous studies [33, 42].
Other studies have also reported contrasting results where
high level of education was associated with low compliance
[43, 44]
Findings from this study showed that government and
private employees had significant increased odds for non-
compliance to AHT. It is assumed that patients who are
employed can afford the cost of medication and treatment
and hence more likely to be compliant to medication. How-
ever, high noncompliance was observed among employed
participants and this could be attributed to the busy work
schedules and patients having less time for self-care or
management [45, 46]. Other studies have also reported
contrasting results whereby prevalence of noncompliance to
AHT was found to be higher among unemployed individuals
with low socioeconomic status [24]. Furthermore, partic-
ipants with regular source of income had lower odds for
noncompliance to AHT. This result is supported by cross-
sectional studies conducted in Egypt, by Awad et al. [47] and
in Saudi Arabia and Sudan by EL-Zubier [48] who reported
that the insufficient income will possibly affect compliance
principally if patient is receiving numerous drugs or the
drug is expensive. Distribution of participants by reasons of
compliant to antihypertensive medication was determined.
Themain reason for noncompliance reported by participants
was cost of medication, stopping medication when feeling
well, fear of side effects, forgetfulness, and use of traditional
medicine. These findings are supported by reports from
previous cross-sectional studies conducted by Almas et al.
[33] and Hashim et al. [49].
Although findings in this study concur with reports from
other studies and highlight the burden of noncompliance to
AHT in the Kintampo municipality and probable associated
factors such as health beliefs and lifestyle, there were some
8 International Journal of Hypertension
limitations. This was a cross-sectional study conducted with
small sample size which limited our ability to explain the
causal correlations between variables and noncompliance.
All participants came from one municipality, and thus, the
findings may not represent all of Ghana. The current HBM
only includes five cognitively based constructs. It does not
consider the emotional, environmental, and social compo-
nents of health behaviour, which should be added to theHBM
in future studies.
5. Conclusion
The study showed that noncompliance to AHTwas consider-
ably high andHBM is generally reliable in assessing treatment
noncompliance in the Ghanaian hypertensive patients. The
study further identified sociodemographic characteristics
such as educational level, occupational status, and regu-
lar source of income to be significantly associated with
noncompliance in the hypertensive patients higher level of
perceived barriers; susceptibility and severity were signif-
icant predictors of noncompliance: therefore, intervention
programmes for noncompliance can be directed towards a
greater involvement of increased perceived benefits, cues
to action, and personality characteristics such as locus of
control.
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